Financial Health Report: Dianthus Therapeutics Inc (DNTH)’s Ratios Tell a Tale

In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Dianthus Therapeutics Inc (NASDAQ: DNTH) closed the day trading at $25.49 down -3.26% from the previous closing price of $26.35. In other words, the price has decreased by -$3.26 from its previous closing price. On the day, 1.85 million shares were traded. DNTH stock price reached its highest trading level at $27.555 during the session, while it also had its lowest trading level at $25.35.

Ratios:

For a better understanding of DNTH, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 18.30 and its Current Ratio is at 18.30. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Oppenheimer on October 03, 2024, initiated with a Outperform rating and assigned the stock a target price of $48.

On July 26, 2024, Robert W. Baird started tracking the stock assigning a Outperform rating and target price of $58.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, DNTH now has a Market Capitalization of 779879296 and an Enterprise Value of 473614624. For the stock, the TTM Price-to-Sale (P/S) ratio is 140.49 while its Price-to-Book (P/B) ratio in mrq is 2.22. Its current Enterprise Value per Revenue stands at 88.262 whereas that against EBITDA is -5.719.

Stock Price History:

Over the past 52 weeks, DNTH has reached a high of $33.77, while it has fallen to a 52-week low of $6.58. The 50-Day Moving Average of the stock is -7.81%, while the 200-Day Moving Average is calculated to be -2.62%.

Shares Statistics:

Over the past 3-months, DNTH traded about 201.59K shares per day on average, while over the past 10 days, DNTH traded about 224470 shares per day. A total of 29.60M shares are outstanding, with a floating share count of 20.25M. Insiders hold about 31.60% of the company’s shares, while institutions hold 77.69% stake in the company. Shares short for DNTH as of 1730332800 were 5096640 with a Short Ratio of 25.28, compared to 1727654400 on 4973755. Therefore, it implies a Short% of Shares Outstanding of 5096640 and a Short% of Float of 24.430001.

Most Popular